Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gwenan M Knight

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
The Lancet. Microbe|December 14, 2020
Definition of a genetic relatedness cutoff to exclude recent transmission of meticillin-resistant <i>Staphylococcus aureus</i>: a genomic epidemiology analysisFrancesc Coll, Kathy E Raven, Gwenan M Knight, et al.
Infection Prevention in Practice|December 6, 2021
Effectiveness of infection prevention and control interventions, excluding personal protective equipment, to prevent nosocomial transmission of SARS-CoV-2: a systematic review and call for actionYalda Jafari, Mo Yin, Cherry Lim, et al.
BMC Medicine|September 4, 2020
COVID-19 length of hospital stay: a systematic review and data synthesisEleanor M Rees, Emily S Nightingale, Yalda Jafari, et al.
Elife|August 25, 2020
The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise shipJon C Emery, Timothy W Russell, Yang Liu, et al.
Elife|February 16, 2021
Antimicrobial resistance and COVID-19: Intersections and implicationsGwenan M Knight, Rebecca E Glover, C Finn McQuaid, et al.
The Lancet. Infectious Diseases|February 13, 2016
The transmission of Mycobacterium tuberculosis in high burden settingsTom A Yates, Palwasha Y Khan, Gwenan M Knight, et al.
BMC Infectious Diseases|June 18, 2022
The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020Gwenan M Knight, Thi Mui Pham, James Stimson, et al.
Nature Communications|October 4, 2023
Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysisNicolas A Menzies, Brian W Allwood, Anna S Dean, et al.
Journal of Clinical Microbiology|October 9, 2025
<i>In vitro</i> activity of antibiotic monotherapy and combination therapy with bacteriophages against <i>Staphylococcus aureus</i> LVAD-driveline infectionsMichèle M Molendijk, Nelianne J Verkaik, Corné P de Vogel, et al.
Journal of Infection and Public Health|November 18, 2023
Why local antibiotic resistance data matters - Informing empiric prescribing through local data collation, app design and engagement in ZambiaSombo Fwoloshi, Uchizi Chola, Ruth Nakazwe, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
The Lancet. Microbe|December 14, 2020
Definition of a genetic relatedness cutoff to exclude recent transmission of meticillin-resistant <i>Staphylococcus aureus</i>: a genomic epidemiology analysisFrancesc Coll, Kathy E Raven, Gwenan M Knight, et al.
Infection Prevention in Practice|December 6, 2021
Effectiveness of infection prevention and control interventions, excluding personal protective equipment, to prevent nosocomial transmission of SARS-CoV-2: a systematic review and call for actionYalda Jafari, Mo Yin, Cherry Lim, et al.
BMC Medicine|September 4, 2020
COVID-19 length of hospital stay: a systematic review and data synthesisEleanor M Rees, Emily S Nightingale, Yalda Jafari, et al.
Elife|August 25, 2020
The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise shipJon C Emery, Timothy W Russell, Yang Liu, et al.
Elife|February 16, 2021
Antimicrobial resistance and COVID-19: Intersections and implicationsGwenan M Knight, Rebecca E Glover, C Finn McQuaid, et al.
The Lancet. Infectious Diseases|February 13, 2016
The transmission of Mycobacterium tuberculosis in high burden settingsTom A Yates, Palwasha Y Khan, Gwenan M Knight, et al.
BMC Infectious Diseases|June 18, 2022
The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020Gwenan M Knight, Thi Mui Pham, James Stimson, et al.
Nature Communications|October 4, 2023
Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysisNicolas A Menzies, Brian W Allwood, Anna S Dean, et al.
Journal of Clinical Microbiology|October 9, 2025
<i>In vitro</i> activity of antibiotic monotherapy and combination therapy with bacteriophages against <i>Staphylococcus aureus</i> LVAD-driveline infectionsMichèle M Molendijk, Nelianne J Verkaik, Corné P de Vogel, et al.
Journal of Infection and Public Health|November 18, 2023
Why local antibiotic resistance data matters - Informing empiric prescribing through local data collation, app design and engagement in ZambiaSombo Fwoloshi, Uchizi Chola, Ruth Nakazwe, et al.
Pageof 8